Original Research
Published on 10 Sep 2020
Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01771
- 5,425 views
- 7 citations
Type at least 3 characters
1,011 articles
Articles
Review
Published on 08 Sep 2020
Role of the Sterol Regulatory Element Binding Protein Pathway in Tumorigenesis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01788
- 10,975 views
- 25 citations
Original Research
Published on 03 Sep 2020
Evaluation of Artificial Intelligence in Participating Structure-Based Virtual Screening for Identifying Novel Interleukin-1 Receptor Associated Kinase-1 Inhibitors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01769
- 4,027 views
- 13 citations
Original Research
Published on 02 Sep 2020
Fluorouracil Supplemented With Oxaliplatin or Irinotecan for Solid Tumors: Indications From Clinical Characteristics and Health Outcomes of Patients
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01542
- 3,144 views
- 2 citations
Editorial
Published on 02 Sep 2020
Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis)
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01675
- 1,403 views
Case Report
Published on 28 Aug 2020
Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01760
- 2,778 views
- 5 citations
Original Research
Published on 28 Aug 2020
Hypofractionated Radiotherapy in Combination With Chemotherapy Improves Outcome of Patients With Esophageal Carcinoma Tracheoesophageal Groove Lymph Node Metastasis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01540
- 2,164 views
- 3 citations
Original Research
Published on 26 Aug 2020
Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01545
- 4,498 views
- 19 citations
Review
Published on 21 Aug 2020
Targeting Cullin-RING E3 Ligases for Radiosensitization: From NEDDylation Inhibition to PROTACs
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01517
- 7,629 views
- 10 citations
Original Research
Published on 19 Aug 2020
Association of the Trough, Peak/Trough Ratio of Imatinib, Pyridine–N-Oxide Imatinib and ABCG2 SNPs 34 G>A and SLCO1B3 334 T>G With Imatinib Response in Egyptian Chronic Myeloid Leukemia Patients
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01348
- 3,984 views
- 12 citations
Original Research
Published on 19 Aug 2020
Upregulated hsa_circ_0005785 Facilitates Cell Growth and Metastasis of Hepatocellular Carcinoma Through the miR-578/APRIL Axis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01388
- 2,663 views
- 18 citations
Brief Research Report
Published on 19 Aug 2020
Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01354
- 2,997 views
Case Report
Published on 18 Aug 2020
Pembrolizumab in a Patient With Heavily Pre-Treated Squamous Cell Thymic Carcinoma and Cardiac Impairment: A Case Report and Literature Review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01478
- 5,249 views
- 8 citations
Original Research
Published on 14 Aug 2020
mTOR Promotes Tissue Factor Expression and Activity in EGFR-Mutant Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01615
- 5,055 views
- 6 citations
Original Research
Published on 13 Aug 2020
Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01273
- 5,679 views
- 20 citations
Original Research
Published on 11 Aug 2020
2-O-Methylmagnolol, a Magnolol Derivative, Suppresses Hepatocellular Carcinoma Progression via Inhibiting Class I Histone Deacetylase Expression
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.01319
- 3,233 views
- 7 citations